Liver Disease

Disease State Hub

From the Journal

Case in Point

A Young Woman Presenting with Diffuse Abdominal Pain

05/08/2014

Philip Pancari, MD; Ronald N. Rubin, MD

A 41-year-old woman presents with diffuse abdominal pain, rated 10/10 in severity, described as “deep and cramping.”

05/08/2014

Research Summaries

Research Summary

Can Increasing Follow-up After Patients With Hepatitis C Achieve Sustained Virologic Response Reduce Reinfection Rates?

10/16/2024

Miranda Manier, BA

In a cohort study, researchers observed a significant decrease in incident reinfection among patients with Hepatitis C who received increased follow-up after achieving sustained virologic response.

10/16/2024

FDA Alert

FDA Approves First Treatment for Adults With MASH, Serious Liver Disease

03/21/2024

Anthony Calabro, MA

The FDA approved resmetirom for the treatment of adults with metabolic dysfunction-associated steatohepatitis with moderate-to-advanced liver fibrosis.

03/21/2024

FDA Alert

FDA Approves Liver-Directed Treatment for Adults With Metastatic Uveal Melanoma

09/11/2023

Anthony Calabro, MA

The FDA approval follows a single-arm, multicenter, open-label trial in 91 patients with uveal melanoma with unresectable hepatic metastases.

09/11/2023

research summary

CVD Risk Is Increased in Patients with HIV and NAFLD, Liver Fibrosis

04/26/2023

Leigh Precopio

To better understand the relationship between cardiovascular disease and liver disease in individuals with HIV, researchers examined both traditional risk factors and HIV-specific risk factors of the...

04/26/2023

Research Summary

Direct-Acting Antiviral Therapy Lowers Mortality, Cancer Risk in Patients With Hepatitis C

02/01/2023

The researchers set out to determine the mortality risk and complications associated with direct-acting antiviral treatment in patients with chronic hepatitis C.

02/01/2023

October 2024

Current Issue

October 2024

Volume 64

Issue 9